Literature DB >> 10049336

Time-resolved fluorescence investigation of the human immunodeficiency virus type 1 nucleocapsid protein: influence of the binding of nucleic acids.

E Bombarda1, A Ababou, C Vuilleumier, D Gérard, B P Roques, E Piémont, Y Mély.   

Abstract

Depending on the HIV-1 isolate, MN or BH10, the nucleocapsid protein, NCp7, corresponds to a 55- or 71-amino acid length product, respectively. The MN NCp7 contains a single Trp residue at position 37 in the distal zinc finger motif, and the BH10 NCp7 contains an additional Trp, at position 61 in the C-terminal chain. The time-resolved intensity decay parameters of the zinc-saturated BH10 NCp7 were determined and compared to those of single-Trp-containing derivatives. The fluorescence decay of BH10 NCp7 could be clearly represented as a linear combination (with respect to both lifetimes and fractional intensities) of the individual emitting Trp residues. This suggested the absence of interactions between the two Trp residues, a feature that was confirmed by molecular modeling and fluorescence energy transfer studies. In the presence of tRNAPhe, taken as a RNA model, the same conclusions hold true despite the large fluorescence decrease induced by the binding of tRNAPhe. Indeed, the fluorescence of Trp37 appears almost fully quenched, in keeping with a stacking of this residue with the bases of tRNAPhe. Despite the multiple binding sites in tRNAPhe, the large prevalence of ultrashort lifetimes, associated with the stacking of Trp37, suggests that this stacking constitutes a major feature in the binding process of NCp7 to nucleic acids. In contrast, Trp61 only stacked to a small extent with tRNAPhe. The behavior of this residue in the tRNAPhe-NCp7 complexes appeared to be rather heterogeneous, suggesting that it does not constitute a major determinant in the binding process. Finally, our data suggested that the binding of NCp7 proteins from the two HIV-1 strains to nonspecific nucleic acid sequences was largely similar.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10049336      PMCID: PMC1300132          DOI: 10.1016/S0006-3495(99)77315-7

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  46 in total

1.  Sequence-specific binding of human immunodeficiency virus type 1 nucleocapsid protein to short oligonucleotides.

Authors:  R J Fisher; A Rein; M Fivash; M A Urbaneja; J R Casas-Finet; M Medaglia; L E Henderson
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

2.  Binding of the nucleocapsid protein of type 1 human immunodeficiency virus to nucleic acids studied using phosphorescence and optically detected magnetic resonance.

Authors:  J Q Wu; A Ozarowski; A H Maki; M A Urbaneja; L E Henderson; J R Casas-Finet
Journal:  Biochemistry       Date:  1997-10-14       Impact factor: 3.162

Review 3.  Fluorescence methods for studying equilibrium macromolecule-ligand interactions.

Authors:  M R Eftink
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

4.  Theoretical aspects of DNA-protein interactions: co-operative and non-co-operative binding of large ligands to a one-dimensional homogeneous lattice.

Authors:  J D McGhee; P H von Hippel
Journal:  J Mol Biol       Date:  1974-06-25       Impact factor: 5.469

Review 5.  Time-resolved fluorescence of proteins.

Authors:  J M Beechem; L Brand
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

6.  Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1.

Authors:  J L Darlix; C Gabus; M T Nugeyre; F Clavel; F Barré-Sinoussi
Journal:  J Mol Biol       Date:  1990-12-05       Impact factor: 5.469

7.  Determination of the excited-state lifetimes of the tryptophan residues in barnase, via multifrequency phase fluorometry of tryptophan mutants.

Authors:  K Willaert; R Loewenthal; J Sancho; M Froeyen; A Fersht; Y Engelborghs
Journal:  Biochemistry       Date:  1992-01-28       Impact factor: 3.162

8.  Structure of the complex between the HIV-1 nucleocapsid protein NCp7 and the single-stranded pentanucleotide d(ACGCC).

Authors:  N Morellet; H Déméné; V Teilleux; T Huynh-Dinh; H de Rocquigny; M C Fournié-Zaluski; B P Roques
Journal:  J Mol Biol       Date:  1998-10-23       Impact factor: 5.469

9.  Phosphorescence and optically detected magnetic resonance investigation of the binding of the nucleocapsid protein of the human immunodeficiency virus type 1 and related peptides to RNA.

Authors:  W C Lam; A H Maki; J R Casas-Finet; J W Erickson; B P Kane; R C Sowder; L E Henderson
Journal:  Biochemistry       Date:  1994-09-06       Impact factor: 3.162

10.  RNA secondary structure and binding sites for gag gene products in the 5' packaging signal of human immunodeficiency virus type 1.

Authors:  J Clever; C Sassetti; T G Parslow
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

View more
  9 in total

1.  DNA condensation by the nucleocapsid protein of HIV-1: a mechanism ensuring DNA protection.

Authors:  G Krishnamoorthy; Bernard Roques; Jean-Luc Darlix; Yves Mély
Journal:  Nucleic Acids Res       Date:  2003-09-15       Impact factor: 16.971

2.  Characterization of the inhibition mechanism of HIV-1 nucleocapsid protein chaperone activities by methylated oligoribonucleotides.

Authors:  Sergiy V Avilov; Christian Boudier; Marina Gottikh; Jean-Luc Darlix; Yves Mély
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

Review 3.  Properties and functions of the nucleocapsid protein in virus assembly.

Authors:  Delphine Muriaux; Jean-Luc Darlix
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

4.  On the involvement of electron transfer reactions in the fluorescence decay kinetics heterogeneity of proteins.

Authors:  A Ababou; E Bombarda
Journal:  Protein Sci       Date:  2001-10       Impact factor: 6.725

5.  Nucleic acid binding and chaperone properties of HIV-1 Gag and nucleocapsid proteins.

Authors:  Margareta Cruceanu; Maria A Urbaneja; Catherine V Hixson; Donald G Johnson; Siddhartha A Datta; Matthew J Fivash; Andrew G Stephen; Robert J Fisher; Robert J Gorelick; Jose R Casas-Finet; Alan Rein; Ioulia Rouzina; Mark C Williams
Journal:  Nucleic Acids Res       Date:  2006-01-30       Impact factor: 16.971

6.  Dynamic interactions of the HIV-1 Tat with nucleic acids are critical for Tat activity in reverse transcription.

Authors:  Christian Boudier; Nicolas Humbert; Françoise Chaminade; Yingying Chen; Hugues de Rocquigny; Julien Godet; Olivier Mauffret; Philippe Fossé; Yves Mély
Journal:  Nucleic Acids Res       Date:  2013-10-22       Impact factor: 16.971

7.  Synthesis of distal and proximal fleximer base analogues and evaluation in the nucleocapsid protein of HIV-1.

Authors:  Therese Ku; Natalie Lopresti; Matthew Shirley; Mattia Mori; Jan Marchant; Xiao Heng; Maurizio Botta; Michael F Summers; Katherine L Seley-Radtke
Journal:  Bioorg Med Chem       Date:  2019-05-15       Impact factor: 3.641

8.  Probing dynamics of HIV-1 nucleocapsid protein/target hexanucleotide complexes by 2-aminopurine.

Authors:  S V Avilov; E Piemont; V Shvadchak; H de Rocquigny; Y Mély
Journal:  Nucleic Acids Res       Date:  2007-12-17       Impact factor: 16.971

9.  Modulation of microtubule assembly by the HIV-1 Tat protein is strongly dependent on zinc binding to Tat.

Authors:  Caroline Egelé; Pascale Barbier; Pascal Didier; Etienne Piémont; Diane Allegro; Olivier Chaloin; Sylviane Muller; Vincent Peyrot; Yves Mély
Journal:  Retrovirology       Date:  2008-07-09       Impact factor: 4.602

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.